National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1485544

Government Disclaimer on use of this data

History of Changes from the VAERS Wayback Machine

First Appeared on 8/6/2021

VAERS ID: 1485544
VAERS Form:2
Age:35.0
Sex:Female
Location:Foreign
Vaccinated:2021-06-08
Onset:0000-00-00
Submitted:0000-00-00
Entered:2021-07-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 3002332 / 1 - / OT

Administered by: Unknown      Purchased by: ??
Symptoms: Abortion spontaneous, Maternal exposure during pregnancy, SARS-CoV-2 test

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: CYCLIZINE; FOLIC ACID
Current Illness: Motor neuron disease (carrier of I114T-MND gene)
Preexisting Conditions: Medical History/Concurrent Conditions: Pregnancy (Patient no longer pregnant at the time of reporting.)
Allergies:
Diagnostic Lab Data: Test Date: 2021; Test Name: COVID-19 virus test; Test Result: Negative ; Result Unstructured Data: Negative
CDC 'Split Type': GBMODERNATX, INC.MOD20212

Write-up: Miscarriage; Early miscarriage; Maternal exposure during pregnancy; This regulatory authority prospective pregnancy case was reported by a pharmacist and describes the occurrence of ABORTION SPONTANEOUS (Miscarriage) and ABORTION SPONTANEOUS (Early miscarriage) in a 35-year-old female patient (gravida 1) who received mRNA-1273 (Moderna CoviD-19 Vaccine) (batch no. 3002332) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient''s past medical history included Pregnancy (Patient no longer pregnant at the time of reporting.). Concurrent medical conditions included Motor neuron disease (carrier of I114T-MND gene). Concomitant products included FOLIC ACID for Folic acid supplementation, CYCLIZINE from 10-Jun-2021 to an unknown date for Nausea. On 08-Jun-2021, the patient received first dose of mRNA-1273 (Moderna CoviD-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced ABORTION SPONTANEOUS (Miscarriage) (seriousness criterion medically significant), ABORTION SPONTANEOUS (Early miscarriage) (seriousness criterion medically significant) and MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy). The delivery occurred on an unknown date. For neonate 1, The outcome was reported as Spontaneous Abortion NOS. Patient was exposed to the medicine first-trimester (1-12 weeks). At the time of the report, ABORTION SPONTANEOUS (Miscarriage) and ABORTION SPONTANEOUS (Early miscarriage) had resolved and MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, SARS-CoV-2 test: negative (Negative) Negative. The action taken with mRNA-1273 (Moderna CoviD-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna CoviD-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient experienced miscarriage which was noted at 12 week scan. Patient stated that heart beat of the fetus was stopped around 9 weeks and she took vaccine a week prior to this. Treatment information was not provided. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender''s Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1485544&WAYBACKHISTORY=ON


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166